1. Home
  2. BJDX

BJDX

Bluejay Diagnostics Inc.

Logo Bluejay Diagnostics Inc.

Health Care

Medical Specialities

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Bluejay Diagnostics Inc is a medical diagnostics company. It is engaged in developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

Founded: 2015 Country:
United States
United States
Employees: 10 City: ACTON
Market Cap: 1.6M IPO Year: 2021
Target Price: N/A AVG Volume (30 days): 41.6K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -9.08 EPS Growth: N/A
52 Week Low/High: $0.60 - $13.98 Next Earning Date: 05-08-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: